Quizartinib
Daiichi Sankyo
['leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'quantum-first', 'leukemia', 'quizartinib', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'heidelberg']
congress|#eha2023 richard schlenk presents the results from the quantum-first trial evaluating allo-hct in 1st complete remission + quizartinib. pts on quiz who underwent allo-hct in cr1 had longer os than pts on placebo #amlsm #leukemia #leusm #medicalcongress 
The AML Hub is an evidence-based online resource on Acute Myeloid Leukemia (AML), for academic researchers and treating clinicians. #leusm